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Abstract. The benefits of the present proteomic approaches for the life science 
community are limited by 3 major problems. 1. The identification of proteins, 
regardless whether the peptide mass fingerprint or the shot-gun approach is 
used, usually is based on an incomplete set of peptides leaving large parts of 
the full amino acid sequence and other structural details of the original protein 
species in the dark; 2. Missing validation of many of the identified proteins by 
orthogonal biological experiments thus risking false positive results; 3. Missing 
standardization in nomenclature. In sum these problems may hinder progress in 
life science projects employing proteomic strategies and may be especially 
risky for system biology approaches since the ambiguities resulting from the 
above mentioned problems may cause wrong models. It is recommended to 
guide future proteome analytical investigations by a hypothesis and to focus to 
a smaller number of proteins which should ideally be analyzed in detail 
covering 100 % sequence coverage as well as all posttranslational 
modifications and will allow validation by additional biological experiments. 
1   Introduction 
In the past 10 years an impressive increase in publications about proteome analytical 
investigations can be recognized. However there are many analytical problems which 
are yet not really well solved such as the quantification problem or the resolution of 
low abundant proteins. Beside the individual restrictions, which accompany every 
currently available proteomic method, there are 3 major obstacles, which will be 
discussed here. 
2   Discussion 
 2.1 The identification problem 
The first problem concerns the protein identification. Independently from the 
approach, either peptide mass fingerprint (PMF) or sequencing of peptides of a digest 
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by MS/MS experiments, the identification of each individual protein is based on the 
mass spectrometric data derived from only a few of its peptides, which cover only a 
part of the total sequence of the protein. As a result splicing variants, truncations or 
mutations can not be identified. In addition in many cases no or only minor 
information about posttranslational modifications are yielded. Are these protein 
species relevant in number? Answers can be found in many publications presenting 
the results of 2-dimensional electrophoresis (2DE) such as the article from Klose et 
al.  [1]. In this publication 24 protein species of the γ-enolase-2 and 52 species of 
HSP-70 were identified in mouse brain tissue. Are these protein species biologically 
relevant? Reviews about HSP-70 [2, 3] show, that this protein is involved in many 
different cell physiological processes. E.g. the extent of its in vitro phosphorylation 
was found to be significantly reduced by heat stress [4], thus demonstrating, that the 
phosphorylation state is associated with environmental conditions. Not only 
phosphorylation or other posttranslational modifications (PTMs) but also protein 
truncations play an important role in the regulation of protein function, as we know 
from protease-activated receptors (PAR) [5]. However, none of the common 
proteomic approaches clarifies the question, by which structural details individual 
protein species are characterized. Furthermore, with those proteomic approaches, 
which start with enzymatic digestions (shot-gun approach), followed by 
chromatographic separation prior to MS/MS analysis, it is nearly impossible to 
answer the question, which protein species of a protein were present in a sample. 
Quantification of proteins using the shot-gun approach may even yield results which 
are completely wrong since a defined peptide fragment detected by MS may originate 
from different protein species with identical amino acid sequence, which most 
probably differ in their concentration as well as in their functions. For example the 
activity of many enzymes can be switched on and off by phosphorylation and  
depshosphorylation.  Both protein species in this case differ only by one phosphate 
group, which is bound covalently to an amino acid of the phosphorylated species. 
After the digestion of both protein species, the origin of the peptides can not be 
distinguished anymore with the exception of the phosphorylated peptide. As a result 
it is impossible to answer the biologically important question about the ratio of the 
active and the inactive enzyme. 
 
Thus, protein analytical methods are urgently needed, which allow a comprehensive 
analysis of the total structure of protein species and their quantification. A new 
promising strategy towards these requirements is the top-down mass spectrometric 
approach, using the Fourier transform ion cyclotron resonance (FT-ICR)-MS 
technology, although this approach for the analysis of intact proteins is still in its 
infancy. In the future top-down proteomics may enable the study of intact proteins 
including their PTMs. Nevertheless, further progress in the FT-ICR technology is 
necessary to be able to analyze larger proteins. Furthermore advances in sample 
preparation and separation of intact proteins and data processing are needed to realize 
the potential of FT-ICR-MS for proteome analyses. 
2.2   The validation problem  
The second problem results from the large number of identified proteins, especially in 
protein mapping and other high-throughput studies. In these cases experimental 
verification of the identity of each protein usually is not possible, since the necessary 
biological experiments are much more time consuming than the automated protein 
identification procedure. Here, it may be beneficial to link the proteomic study to a 
hypothesis, which will reduce the number of proteins of interest from hundreds to a 
few. These proteins of interest after their identification can then be investigated by 
other techniques in more detail to validate their biological relevance in 
correspondence to their function. This procedure will also help to reduce the number 
of wrongly identified proteins. 
2.3   The problem of nomenclature 
The third problem is given by the protein-nomenclature, which is not standardized 
yet. Still, many different synonyms are used for individual proteins, which are 
transcripts of one single gene. The protein-disulfid-isomerase A3 is a representative 
example. The SwissProt accession number is P30101. SwissProt lists the synonyms 
EC 5.3.4.1, disulfide isomerase ER-60,  ERp60, 58 kDa microsomal protein, p58, 
ERp57 and 58 kDa glucose regulated protein. A SwissProt search with “synonym” 
EC 5.3.4.1 finds a whole family of protein-disulfide-isomerases with the accession 
numbers P07237, Q13087, P30101, P13667, Q14554, Q15084 and Q96JJ7. A search 
with P30101 in the protein data base of the NCBI [6] results in 1 hit. In contrast a 
search with p58 results in 330 hits, thus demonstrating that this name is used for 
many different proteins with completely different amino acid sequences. Searching 
PubMed for “proteome” and ER60 yields 3 hits [7 - 9], which all of them are different 
from those 3 hits using “proteome” and “ERp57” [10 - 12]. Some authors obviously 
recognized this problem and therefore introduced a term consisting of 2 synonyms 
(ER60/ERp57) [13] or even a name formed by 4 synonyms: “glucose-regulated 
protein 58, GRP58/ERp57/ER-60” [14]. The missing standardization of the 
nomenclature of proteins may result in inappropriate conclusions concerning the 
relationship of function and identity of proteins and in the worst case may generate 
incorrect models of biochemical mechanisms, especially if data-base oriented 
modeling is performed. 
This problem will be solved only if all data bases and all journals will follow the 
same standardized rules for the nomenclature of proteins, which allows an 
unambiguous identification of the individual protein species including and addressing 
its structural features. It is suggested that additionally to the already existing names 
the accession numbers should be used, with terms added, which characterize the 
structural properties of the protein species. 
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